Windtree Therapeutics, Inc. - WINT
About Gravity Analytica
Recent News
- 04.15.2025 - Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
- 04.15.2025 - Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
- 04.15.2025 - Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
- 03.24.2025 - Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules
- 03.24.2025 - Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules
- 03.24.2025 - Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules
- 03.20.2025 - Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
- 03.20.2025 - Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
- 03.20.2025 - Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
- 03.04.2025 - Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure